Acadia Pharmaceuticals

ACADNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$4.548 B

$26.40 -3.28%

Close of 21 Sept 2026

Revenue

$1.07B

#1489 by revenue

Earnings

$391.0M

#726 by earnings

Shares outstanding

172,305,518

Latest filing cover page

P/E ratio

11.6

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#57Edgewise TherapeuticsEWTX$4.85B
#58VeradermicsMANE$4.71B
#59Acadia PharmaceuticalsACAD$4.55B
#60Parabilis MedicinesPBLS$4.50B
#61Genmab A/SGMAB$4.46B

What if Acadia Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.3T

$175,699.85

Per share 6,657× higher

Bitcoin $1.72T

$9,981.13

Per share 378× higher

Nvidia $5.48T

$31,803.15

Per share 1,205× higher

Or at a round number

$10.0B $20.0B $50.0B $100.0B

Where these numbers come from

Share counts and financials for Acadia Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.